Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

PAZOPanib

PAZOPanib
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Votrient TABLET, ORAL 200 mg, 400 mg      
Comments:

At Huntsville Main/W&C/Madison, orders for this medication should be rejected and reviewed by an oncology clinical specialist or an oncology pool member (see second page of the document "Hormone Therapies and Guidance on Oral Chemotherapy") 

Oral Chemotherapy Drug Pharmacist Education

Oral Chemotherapy TOC Information

Votrient medication guide

VOTRIENT is classified as NON-FORMULARY, NOT STOCKED OR ORDERED. This drug is only distributed through specialty pharmacy programs and is not available directly to the hospital. Initiation of therapy should be deferred to the outpatient setting. Inpatients should use their own supply if needed.

Reviewed: March 23, 2010.

Last updated: Mar. 5, 2025






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved